These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 33209482)
21. Adjuvant radiotherapy improves cause specific survival in stage II, not stage III mucinous carcinoma of the rectum. Li Q; Li Y; Dai W; Wang S; Xu Y; Li X; Cai S BMC Cancer; 2017 Jan; 17(1):80. PubMed ID: 28122523 [TBL] [Abstract][Full Text] [Related]
22. Prognosis and value of adjuvant chemotherapy in stage III mucinous colorectal carcinoma. Hugen N; Verhoeven RH; Radema SA; de Hingh IH; Pruijt JF; Nagtegaal ID; Lemmens VE; de Wilt JH Ann Oncol; 2013 Nov; 24(11):2819-24. PubMed ID: 24057984 [TBL] [Abstract][Full Text] [Related]
23. Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study. Gao P; Huang XZ; Song YX; Sun JX; Chen XW; Sun Y; Jiang YM; Wang ZN BMC Cancer; 2018 Mar; 18(1):234. PubMed ID: 29490625 [TBL] [Abstract][Full Text] [Related]
24. Predictive value of mucinous histology in colon cancer: a population-based, propensity score matched analysis. Warschkow R; Tarantino I; Huttner FJ; Schmied BM; Guller U; Diener MK; Ulrich A Br J Cancer; 2016 Apr; 114(9):1027-32. PubMed ID: 26977857 [TBL] [Abstract][Full Text] [Related]
25. Prevalence and survival benefit of adjuvant chemotherapy in stage III colon cancer patients: Comparison of overall and age-stratified results by multivariable modeling and propensity score methodology in a population-based cohort. Hines RB; Bimali M; Johnson AM; Bayakly AR; Collins TC Cancer Epidemiol; 2016 Oct; 44():77-83. PubMed ID: 27513721 [TBL] [Abstract][Full Text] [Related]
26. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database. Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699 [TBL] [Abstract][Full Text] [Related]
27. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer. Sanoff HK; Carpenter WR; Martin CF; Sargent DJ; Meyerhardt JA; Stürmer T; Fine JP; Weeks J; Niland J; Kahn KL; Schymura MJ; Schrag D J Natl Cancer Inst; 2012 Feb; 104(3):211-27. PubMed ID: 22266473 [TBL] [Abstract][Full Text] [Related]
28. Adjuvant chemotherapy for stage II right-sided and left-sided colon cancer: analysis of SEER-medicare data. Weiss JM; Schumacher J; Allen GO; Neuman H; Lange EO; Loconte NK; Greenberg CC; Smith MA Ann Surg Oncol; 2014 Jun; 21(6):1781-91. PubMed ID: 24643898 [TBL] [Abstract][Full Text] [Related]
29. Prognostic Effect of Tumor Sidedness in Colorectal Cancer: A SEER-Based Analysis. Li Y; Feng Y; Dai W; Li Q; Cai S; Peng J Clin Colorectal Cancer; 2019 Mar; 18(1):e104-e116. PubMed ID: 30448100 [TBL] [Abstract][Full Text] [Related]
30. A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis. Yang L; Yu J; Zhang S; Shan Y; Li Y; Xu L; Zhang J; Zhang J J Ovarian Res; 2022 Feb; 15(1):26. PubMed ID: 35168642 [TBL] [Abstract][Full Text] [Related]
31. Post-operative chemotherapy improves the survival of patients with well differentiated widespread metastatic appendiceal non-mucinous adenocarcinomas. Yu T; Fan H; Lv Q; Li J; Wei L; Wang M; Dong J; Cai X Ann Palliat Med; 2021 May; 10(5):5156-5170. PubMed ID: 34044560 [TBL] [Abstract][Full Text] [Related]
32. Hemicolectomy Does Not Provide Survival Benefit for Right-Sided Mucinous Colon Adenocarcinoma. Huang J; Huang Q; Tang R; Chen G; Zhang Y; He R; Zu X; Fu K; Peng X; Xiao S Front Oncol; 2020; 10():608836. PubMed ID: 33598431 [TBL] [Abstract][Full Text] [Related]
33. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer. Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521 [TBL] [Abstract][Full Text] [Related]
34. The prognostic value of signet ring cell histology in stage I/II colon cancer-a population-based, propensity score-matched analysis. Ackermann CJ; Guller U; Jochum W; Schmied BM; Warschkow R Int J Colorectal Dis; 2018 Sep; 33(9):1183-1193. PubMed ID: 29881972 [TBL] [Abstract][Full Text] [Related]
35. The efficacy of chemotherapy and operation in patients with colorectal neuroendocrine carcinoma. Wu Z; Yu D; Zhao S; Gao P; Song Y; Sun Y; Chen X; Wang Z J Surg Res; 2018 May; 225():54-67. PubMed ID: 29605035 [TBL] [Abstract][Full Text] [Related]
36. Value of the log odds of positive lymph nodes for prognostic assessment of colon mucinous adenocarcinoma: Analysis and external validation. Cai H; Xu T; Zhuang Z; Zhang Y; Gao Y; Liu X; Zhuang J; Yang Y; Guan G Cancer Med; 2021 Dec; 10(23):8542-8557. PubMed ID: 34796687 [TBL] [Abstract][Full Text] [Related]
37. Inverse effect of mucinous component on survival in stage III colorectal cancer. Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Yamamoto G; Nishimura Y; Yamaguchi K J Surg Oncol; 2014 Dec; 110(7):851-7. PubMed ID: 25111953 [TBL] [Abstract][Full Text] [Related]
38. The association between small tumor size and poor survival in T4 mucinous adenocarcinoma of colon without distant metastasis. Huang B; Chen C; Ni M; Xue X; Cai G; Cai S J BUON; 2017; 22(1):170-177. PubMed ID: 28365951 [TBL] [Abstract][Full Text] [Related]
39. The use of chemotherapy in older patients with stage II and III colon cancer: Variation by age and era of diagnosis. Green SL; Dawe DE; Nugent Z; Cheung WY; Czaykowski PM J Geriatr Oncol; 2019 Jan; 10(1):132-137. PubMed ID: 30104156 [TBL] [Abstract][Full Text] [Related]